(Q44266130)

1 December 2017

1 reference

title

18F-fluorodeoxyglucose positron emission tomography in the diagnosis of lung cancer (English)

1 reference

positron emission tomography

1 December 2017

main subject

1 reference

Bares R

1

1 reference

1 December 2017

Eschmann SM

series ordinal

2

1 reference

1 December 2017

Friedel G

series ordinal

3

1 reference

1 December 2017

publication date

1 January 2002

1 reference

1 December 2017

published in

Vienna Clinical Weekly

1 reference

1 December 2017

volume

29

1 reference

1 December 2017

issue

5

1 reference

1 December 2017

page(s)

171-175

1 reference

An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Accuracy of F-18 fluorodeoxyglucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities: a retrospective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Visualisation and assessment of the protein synthesis rate of lung cancer using carbon-11 tyrosine and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

FDG-PET imaging for the staging and follow-up of small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Staging non-small cell lung cancer by whole-body positron emission tomographic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Evaluation of the solitary pulmonary nodule by positron emission tomography imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Mediastinal staging of non-small-cell lung cancer with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Use of PET to monitor the response of lung cancer to radiation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Neoadjuvant chemoradiotherapy of stage III non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1563-2571.2002.02043.X

10.1046/J.1563-2571.2002.02043.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference